Organigram Global (OGI) Return on Capital Employed (2019 - 2021)
Organigram Global (OGI) posted quarterly Return on Capital Employed of 54.89% for Q1 2021, up 39.02% on a QoQ basis from 90.01% in Q4 2020.
Organigram Global (OGI) Return on Capital Employed (2019 - 2021) Analysis & Trends
Organigram Global (OGI) has reported Return on Capital Employed for 3 consecutive years, with 54.89% the latest figure, recorded in Q1 2021.
- Quarterly Return on Capital Employed changed N/A year-over-year to 54.89% in Q1 2021, while the trailing twelve-month figure through Feb 2021 was 54.89% (changed N/A YoY) and the FY2025 annual result came in at 4.24%, up 728.0% from the prior year.
- Return on Capital Employed improved to 54.89% in Q1 2021 per OGI's latest filing, from 90.01% in the prior quarter.
- Over the last five years, Return on Capital Employed for OGI reached as high as 4.4% in Q3 2019 and fell as low as 90.01% in Q4 2020.
- A 3-year average of 48.89% and a median of 54.89% in 2021 frame the typical range for Return on Capital Employed.
- The largest YoY upside for Return on Capital Employed was 8731 bps in 2020 against a maximum downside of 8731 bps in 2020.
- Year by year, Return on Capital Employed stood at 4.4% in 2019, then plunged by 2144 bps to 90.01% in 2020, then surged by 39 bps to 54.89% in 2021.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 54.89%, 90.01%, and 82.91% for Q1 2021, Q4 2020, and Q3 2020 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 8.52% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 27.36% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -1.50% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 21.43% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.46% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 20.04% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.24% |
| 10 | Organigram Global | 89.89 Mn | 122.96 Mn | 28.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2021 | -54.89% |
| Nov 30, 2020 | -90.01% |
| Aug 31, 2020 | -82.91% |
| May 31, 2020 | -21.05% |
| Aug 31, 2019 | 4.40% |